How should I treat a 62‑year‑old patient with uncontrolled hypertension despite lisinopril 20 mg, amlodipine 10 mg, and chlorthalidone 25 mg?

Add Spironolactone as Fourth-Line Agent

Your patient meets criteria for resistant hypertension and should be started on spironolactone 25 mg daily as the fourth antihypertensive agent, provided their eGFR is ≥45 mL/min/1.73 m² and serum potassium is normal. 1, 2

Confirming True Resistant Hypertension

Before adding another medication, you need to exclude pseudoresistance:

• Verify medication adherence – This is the most common cause of apparent treatment resistance. Consider directly observed therapy or pill counts 1
• Confirm with out-of-office BP monitoring – Obtain home BP readings or 24-hour ambulatory monitoring to exclude white-coat effect. True resistant hypertension requires home BP ≥135/85 mmHg or 24-hour ambulatory BP ≥130/80 mmHg 3
• Review all medications – Approximately 20% of hypertensive patients use over-the-counter medications that elevate BP, particularly NSAIDs and nasal decongestants. These must be discontinued 1, 2

Optimizing Current Regimen First

Your current regimen is appropriate (ACE inhibitor + CCB + thiazide-like diuretic), but ensure:

• Chlorthalidone is superior to HCTZ – You correctly chose chlorthalidone 25 mg, which provides greater BP reduction and cardiovascular protection than hydrochlorothiazide 1, 2
• Allow adequate time – The recent medication adjustments (made just last week) need 2-4 weeks to reach full effect before declaring treatment failure
• Sodium restriction – Reinforce dietary sodium intake <2,400 mg/day, which significantly enhances diuretic efficacy 4, 5

Fourth-Line Therapy: Mineralocorticoid Receptor Antagonist

Once you've confirmed true resistant hypertension and optimized the current regimen:

Add spironolactone 25-50 mg daily 1, 2. This is the Class I, Level B-R recommendation from the 2025 AHA/ACC guidelines. Clinical trials demonstrate spironolactone reduces 24-hour systolic BP by 6.6-8.7 mmHg compared to placebo in resistant hypertension, with superior efficacy compared to doxazosin or bisoprolol 1, 2.

Monitoring Requirements for Spironolactone:

• Check serum potassium and creatinine within 1 week, then monthly for 3 months
• Contraindicated if eGFR <45 mL/min/1.73 m² or baseline potassium >5.0 mEq/L 1, 2
• Watch for hyperkalemia (occurs in 4-40% of patients) and antiandrogenic effects (gynecomastia, erectile dysfunction) 2

Alternative Fourth-Line Options

If spironolactone is not tolerated or contraindicated:

1. Amiloride 10-20 mg daily – Equally effective as spironolactone without antiandrogenic effects 2, 6
2. Beta-blocker (bisoprolol or metoprolol succinate) – Particularly if heart rate >70 bpm 1, 5
3. Alpha-blocker (doxazosin) 1, 4
4. Clonidine patch (weekly) or guanfacine (at bedtime) 5

Screen for Secondary Hypertension

Given persistent uncontrolled BP on triple therapy, evaluate for secondary causes 1, 2:

• Primary aldosteronism – Most common in resistant hypertension; check plasma aldosterone/renin ratio
• Obstructive sleep apnea – Screen with STOP-BANG questionnaire
• Renal artery stenosis – Consider if abdominal bruit present or unexplained kidney dysfunction
• Renal parenchymal disease – Check urinalysis for proteinuria, serum creatinine

Target Blood Pressure

Your patient's current BP of 147/78 mmHg remains above the goal of <130/80 mmHg 1, 2. The systolic BP requires further reduction of approximately 17 mmHg to reach target.

Common Pitfalls to Avoid

• Don't add multiple medications simultaneously – This makes it impossible to identify which agent caused side effects
• Don't use HCTZ instead of chlorthalidone – You made the correct choice; HCTZ is less effective for resistant hypertension 1, 7
• Don't skip adherence assessment – Non-compliance masquerading as resistant hypertension is extremely common and leads to unnecessary polypharmacy 8
• Don't forget lifestyle modification – Weight loss, sodium restriction, and exercise remain essential even with multiple medications 5